Literature DB >> 25845565

Use of proteasome inhibitors.

Sondra L Downey1, Bogdan I Florea2, Herman S Overkleeft2, Alexei F Kisselev1.   

Abstract

Proteasome inhibitors are indispensable research tools in immunology and cell biology. With numerous proteasome inhibitors available commercially, choosing the appropriate compound for a biological experiment may be challenging, especially for a novice. This unit provides an overview of the proteasome inhibitors commonly used in research. It discusses how to select an appropriate highly specific inhibitor, its concentration, and length of exposure for mammalian cell culture experiments. In addition, assays that can be used to confirm proteasome inhibition are discussed.
Copyright © 2015 John Wiley & Sons, Inc.

Entities:  

Keywords:  boronates; peptide aldehydes; peptide epoxyketones; proteosome inhibitors

Mesh:

Substances:

Year:  2015        PMID: 25845565     DOI: 10.1002/0471142735.im0910s109

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  3 in total

1.  Inhibitors of the ubiquitin proteasome system block myofibril assembly in cardiomyocytes derived from chick embryos and human pluripotent stem cells.

Authors:  Jushuo Wang; Yingli Fan; Chenyan Wang; Syamalima Dube; Bernard J Poiesz; Dipak K Dube; Zhen Ma; Jean M Sanger; Joseph W Sanger
Journal:  Cytoskeleton (Hoboken)       Date:  2022-05-24

2.  Induction of apoptosis via proteasome inhibition in leukemia/lymphoma cells by two potent piperidones.

Authors:  Lisett Contreras; Ruben I Calderon; Armando Varela-Ramirez; Hong-Yu Zhang; Yuan Quan; Umashankar Das; Jonathan R Dimmock; Rachid Skouta; Renato J Aguilera
Journal:  Cell Oncol (Dordr)       Date:  2018-08-07       Impact factor: 6.730

3.  Milder degenerative effects of Carfilzomib vs. Bortezomib in the Drosophila model: a link to clinical adverse events.

Authors:  Eleni N Tsakiri; Evangelos Terpos; Eleni-Dimitra Papanagnou; Efstathios Kastritis; Vincent Brieudes; Maria Halabalaki; Tina Bagratuni; Bogdan I Florea; Herman S Overkleeft; Luca Scorrano; Alexios-Leandros Skaltsounis; Meletios A Dimopoulos; Ioannis P Trougakos
Journal:  Sci Rep       Date:  2017-12-19       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.